Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia
NCT02120781Phase 2Completed
- Sponsor
- Castle Creek Biosciences
- Start
- Mar 2014
- Primary completion
- Apr 2016
- Modality
- Bone Marrow HSCs, Peripheral Blood HSCs
- Countries
- 1
01
Overview
A Phase 2 trial of azficel-t in vocal fold scarring, age-related dysphonia, sponsored by Castle Creek Biosciences. Started Mar 2014; status: completed.
02
Drugs
azficel-t
03
Conditions
vocal fold scarringage-related dysphonia
Beyond the preview
Go deeper on NCT02120781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02120781.